October 16, 2024

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer – nejm.org

October 15, 2024

Immune Sensitivity Links Race and Survival After Prostate Cancer Immunotherapy – Duke Health

October 14, 2024

Identification of a 5-gene signature panel for the prediction of prostate cancer progression – Nature.com

October 11, 2024

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 – Nature.com

October 10, 2024

Hope for advanced prostate cancer in South Texas: Pluvicto therapy now available at Mays Cancer Center – UT Health San Antonio